Quantitative phosphoproteomic analysis identifies the potential therapeutic target EphA2 for overcoming sorafenib resistance in hepatocellular carcinoma cells
Chih-Ta Chen(National Taiwan University), Lu‐Ping Chow(National Taiwan University)
Cited by 26
Related Papers
Y-Box Binding Protein-1 Promotes Epithelial-Mesenchymal Transition in Sorafenib-Resistant Hepatocellular Carcinoma Cells
|International Journal of Molecular Sciences|2020|46